RVL Pharmaceuticals PLC
(OTCPK:RVLPQ)
$
0.000001
0 (0%)
Market Cap: -
Enterprise Value: 39.00 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 RVL Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript
Mar 16, 2022 / 03:15PM GMT
Release Date Price:
$1.7
(+4.94%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. My name is Balaji Prasad. I lead the specialty pharmaceuticals coverage for Barclays. And continuing on the spectrum on track, our next company is RVL Pharmaceuticals. And we have the management team, including Brian Markison, the CEO and Andy Einhorn, the CFO. Brian and Andy, thank you for taking your time to be here today.
Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO
Yes. Thanks for having us.
Andrew J. Einhorn
RVL Pharmaceuticals plc - CFO
Certainly.
Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO
In sunny Miami today.
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Today -- it's sunny today.
Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO
Being indoors.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot